ZMAX COMPLETE

Serial Number 78432170
606

Registration Progress

Application Filed
Jun 9, 2004
Under Examination
Sep 13, 2005
Approved for Publication
Jun 1, 2005
Published for Opposition
Jun 21, 2005
Registered

Basic Information

Serial Number
78432170
Filing Date
June 9, 2004
Published for Opposition
June 21, 2005
Abandonment Date
March 14, 2006
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 14, 2006
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Christopher N. Bolinger

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description
May 16, 2006 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
May 16, 2006 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 13, 2005 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 21, 2005 PUBO A PUBLISHED FOR OPPOSITION
Jun 1, 2005 NPUB O NOTICE OF PUBLICATION
Mar 7, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 24, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 16, 2005 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2005 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 2, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2004 ALIE A ASSIGNED TO LIE
Aug 3, 2004 ALIE A ASSIGNED TO LIE
Aug 2, 2004 CPEA F EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED
Aug 2, 2004 CPEA O EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED
Aug 2, 2004 XAEC I EXAMINER'S AMENDMENT ENTERED
Jul 31, 2004 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Jul 22, 2004 DOCK D ASSIGNED TO EXAMINER
Jun 16, 2004 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
antibiotic preparation
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005